How does Alecensa work?
Medically reviewed by Melisa Puckey, BPharm. Last updated on Feb 2, 2021.
- Alecensa works to slow down the growth and spread of non-small cell lung cancer by blocking a protein called anaplastic lymphoma kinase (ALK protein).
- A small percentage of patients with non-small cell lung cancer (NSCLC) have a fault in their ALK gene (anaplastic lymphoma kinase gene) that causes it to make an abnormal protein that helps NSCLC grow and spread. By inhibiting the ALK protein, Alecensa reduces the growth of ALK positive metastatic NSCLC.
- Alecensa is only used in metastatic NSCLC that has been tested and confirmed to be ALK positive.
- Alecensa Medication Information: https://www.drugs.com/alecensa.html
- Alecensa Health Professional Information: https://www.drugs.com/pro/alecensa.html
- Alectinib: a review of its use in advanced ALK-rearranged non-small cell lung cancer: https://pubmed.ncbi.nlm.nih.gov/25428710/https://pubmed.ncbi.nlm.nih.gov/25428710/
Related Medical Questions
- How long do you take Alecensa for?
- How effective is Alecensa for ALK-positive NSCLC?
- What is Alecensa used to treat?
- What is the difference between Opdivo and Keytruda?
- Pembrolizumab vs. nivolumab: how do they compare?
- What is the cost of Tecentriq?
- What is the difference between Mvasi and Avastin?
- What is Tagrisso used for?
- What type of cancer is Tecentriq used to treat?
- What type of drug is Libtayo?
- What type of lung cancer is Vizimpro used to treat?
- What type of drug is Lorbrena?
- What type of drug is Alunbrig?
- Alecensa Information for Consumers
- Alecensa Information for Healthcare Professionals (includes dosage details)
- Side Effects of Alecensa (detailed)